Delivery Of The Medicinal Product Fruquintinibum As Part Of The B.4 Drug Program Treatment Of Patients With Color Intestine Cancer

UNIWERSYTECKI SZPITAL KLINICZNY W POZNANIU Poland has Released a tender for Delivery Of The Medicinal Product Fruquintinibum As Part Of The B.4 Drug Program Treatment Of Patients With Color Intestine Cancer in Pharmaceuticals. The tender was released on Oct 09, 2025.

Country - Poland

Summary - Delivery Of The Medicinal Product Fruquintinibum As Part Of The B.4 Drug Program Treatment Of Patients With Color Intestine Cancer

Deadline - Oct 16, 2025

MT reference number - 119758824

Product classification - Medicinal products for the blood, blood-forming organs and the cardiovascular system

Organization Details:

  Address - Poland

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 119758824

  Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: Delivery Of The Medicinal Product Fruquintinibum As Part Of The B.4 Drug Program Treatment Of Patients With Color Intestine Cancerlocal title:: Dostawa produktu leczniczego Fruquintinibum w ramach Programu Lekowego B.4 LECZENIE CHORYCH NA RAKA JELITA GRUBEGOContract Type: : Supply

Mt Ref Id - 119758824

Deadline - Oct 16, 2025

Share

Similar Tenders :